MSCI ACWI IMI Biotech Advance Index

The MSCI ACWI IMI Biotech Advance Index aims to represent the performance of a set of companies across large, mid and small cap representation across Developed Markets (DM) and Emerging Markets (EM) countries, that are associated with research, development, and commercialization of products for treating a broad range of diseases and disorders.
Get in touch
Document downloads
Index code
753363
Index type
Equity
Benchmark administrator
--
Div Yld (%)
0.86
P/E
76.77
P/E Fwd
35.40
P/BV
4.11
Number of constituents
160
Index Market Cap
$2.63 T
Largest constituent Market Cap
$280.76 B
Smallest constituent Market Cap
$471.23 M
Average constituent Market Cap
$16.46 B
Median constituent Market Cap
$4.37 B
Does this benchmark pursue ESG objectives?
No
Data as of April 30, 2025 

Want to learn more about MSCI indexes?
Get in touch.

Contact us